Specifically, SPA17 was a risk factor for poor prognosis of ACC, BLCA, CHOL, CESC, HNSC, GBM, KICH, LGG, LIHC, LUSC, LUAD, PCPG, SARC, SKCM, and UVM. This evidence concerns the gene SPA17 and adrenal cortex carcinoma.